Home › NDC Lookup › RxCUI directory › RxCUI 2701523

Glycerin 150 MG/ML / petrolatum 160 MG/ML / phenylephrine hydrochloride 2.5 MG/ML / pramox... — RxCUI 2701523

Name: Glycerin 150 MG/ML / petrolatum 160 MG/ML / phenylephrine hydrochloride 2.5 MG/ML / p… (RxCUI 2701523)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2701523 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2701523

Official nameGlycerin 150 MG/ML / petrolatum 160 MG/ML / phenylephrine hydrochloride 2.5 MG/ML / pramoxine hydrochloride 10 MG/ML Rectal Cream

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asglycerin 15 % / phenylephrine hydrochloride 0.25 % / pramoxine hydrochloride 1 % / white petrolatum 16 % Rectal Cream

FDA products mapped1

Package NDCs mapped1

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Phenylephrine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It depends on the product. The injection raises low blood pressure during anesthesia and, for some products, septic shock. Eye drops dilate the pupil, nasal products relieve conges...
Be careful. Over-the-counter phenylephrine should not be used with a prescription MAOI or within 2 weeks of stopping one. If you aren't sure whether your medicine is an MAOI, ask m...
With the injection, the most common are nausea, vomiting and headache. Call for help right away if you have chest pain, a very slow heartbeat, or pain or skin changes around the IV...
Stop and talk to a doctor if you get nervousness, dizziness or sleeplessness. Also stop if symptoms last more than 7 days or come with a fever. Don't use more than the label recomm...

📖 Read our full Phenylephrine guide →

🕸️ Concept Web — How Glycerin 150 MG/ML / petrolatum 160 MG/ML / phen... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Glycerin 150 MG/ML / petrolatum 160 MG/ML / phenylephrine hydrochloride 2.5 MG/ML / pramoxine hydrochloride 10 MG/ML Rectal Cream RxCUI 2701523 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 7

The active substance itself — no strength, form, or brand attached yet.
- Glycerin 4910 IN
- Petrolatum 8091 IN
- Phenylephrine 8163 IN
- Pramoxine 34347 IN
- Glycerin / petrolatum / phenylephrine / pramoxine 1008535 MIN
- Phenylephrine hydrochloride 8164 PIN
- Pramoxine hydrochloride 57555 PIN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Glycerin / petrolatum / phenylephrine / pramoxine Rectal Cream 849642 SCDF
- Glycerin / petrolatum / phenylephrine hydrochloride / pramoxine hydrochloride Rectal Cream 2646064 SCDFP
- Glycerin / petrolatum / phenylephrine / pramoxine Rectal Product 1156211 SCDG
- Glycerin / petrolatum / phenylephrine hydrochloride / pramoxine hydrochloride Rectal Product 2659300 SCDGP
- Rectal Cream 316975 DF
- Rectal Product 1151127 DFG
Clinical & branded drugs 4

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Glycerin 150 MG/ML 439847 SCDC
- Petrolatum 160 MG/ML 2701522 SCDC
- Phenylephrine hydrochloride 2.5 MG/ML 997282 SCDC
- Pramoxine hydrochloride 10 MG/ML 828361 SCDC

Showing up to 8 concepts per family — 17 of 17 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Glycerin 150 MG/ML SCDC · 439847
Petrolatum 160 MG/ML SCDC · 2701522
Phenylephrine hydrochloride 2.5 MG/ML SCDC · 997282
Pramoxine hydrochloride 10 MG/ML SCDC · 828361
Glycerin / petrolatum / phenylephrine / pramoxine Rectal Cream SCDF · 849642
Glycerin / petrolatum / phenylephrine hydrochloride / pramoxine hydrochloride Rectal Cream SCDFP · 2646064
Glycerin / petrolatum / phenylephrine / pramoxine Rectal Product SCDG · 1156211
Glycerin / petrolatum / phenylephrine hydrochloride / pramoxine hydrochloride Rectal Product SCDGP · 2659300

📦 FDA Products & Package NDCs

1 product · 1 package NDC

1 package NDC map to RxCUI 2701523 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
10157-2126-01	1 TUBE, WITH APPLICATOR in 1 CARTON (10157-2126-1) / 26 g i...	Tucks Triple Relief Hemorrhoidal	Blistex Inc.	2025-01-06

Observed labelers: Blistex Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.